Skip to main content
SpringerLink
Log in

Weekly semaglutide cost effective for T2DM in Spain

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2019 euros

Reference

  • Martin V, et al. Evaluation of the Long-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Dulaglutide and Sitagliptin in the Spanish Setting Advances in Therapy : 29 Aug 2020. Available from: URL: https://doi.org/10.1007/s12325-020-01464-1

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Weekly semaglutide cost effective for T2DM in Spain. PharmacoEcon Outcomes News 862, 33 (2020). https://doi.org/10.1007/s40274-020-7151-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7151-4

Search

Navigation